Search

Author/Creator Ferrara, R.

1. 25P Platinum-based chemotherapy (PCT) addition to first-line PD-1/PD-L1 inhibitors (ICI) prevent hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) patients (pts) by reducing circulating immature neutrophils. (December 2022)

Authors:
Ferrara, R.; Lo Russo, G.; Ciniselli, C.M.; Bassani, B.; Calareso, G.; Duroni, V.; Di Gregorio, S.; Proto, C.; Prelaj, A.; De Toma, A.; Occhipinti, M.; Brambilla, M.; Manglaviti, S.; Mazzeo, L.; Ganzinelli, M.; De Braud, F.G.M.; Garassino, M.C.; Colombo, M.P.; Verderio, P.; Sangaletti, S.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations. Issue 1 (December 2016)

Authors:
Peretti, U.; Ferrara, R.; Pilotto, S.; Kinspergher, S.; Caccese, M.; Santo, A.; Brunelli, M.; Caliò, A.; Carbognin, L.; Sperduti, I.; Garassino, M.; Chilosi, M.; Scarpa, A.; Tortora, G.; Bria, E.
Journal:
Respiratory research
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. (May 2019)

Authors:
Proto, C.; Ferrara, R.; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L.M.; De Simone, I.; Colombo, M.P.; Sica, A.; Torri, V.; Garassino, M.C.
Journal:
Cancer treatment reviews
Issue:
Volume 75(2019)
Page Start:
39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. (February 2019)

Authors:
Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K.S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R.; Duchemann, B.; Naigeon, M.; Pignon, J.P.; Besse, B.; Chaput, N.
Journal:
European journal of cancer
Issue:
Volume 108(2019)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice. (21st November 2016)

Authors:
Caccese, M.; Ferrara, R.; Pilotto, S.; Carbognin, L.; Grizzi, G.; Caliò, A.; Brunelli, M.; Cuppone, F.; Petraglia, S.; Scarpa, A.; Tortora, G.; Bria, E.
Journal:
Expert opinion on pharmacotherapy
Issue:
Volume 17:Number 17(2016)
Page Start:
2253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. (April 2020)

Authors:
Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 148(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗